UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 6, 2005
VAXGEN, INC.
(Exact name of Registrant as Specified in its Charter)
DELAWARE | 0-26483 | 94-3236309 |
(State or other jurisdiction of
Identification Number) | (Commission File Number) | (I.R.S. Employer
incorporation or organization) |
1000 MARINA BLVD., SUITE 200, BRISBANE, CALIFORNIA 94005
(Address of Principal Administrative Offices)
Registrant’s Telephone Number, Including Area Code: (650) 624-1000
___________________________________________________________________
(Former name or former address, if changed since last report.)
_________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
SECTION 8—OTHER EVENTS
Item 8.01. Other Events.
On June 6, 2005, VaxGen, Inc. issued a press release entitled, “VaxGen Names Kevin Lee Acting CFO Following Resignation of James Cunha; Company Provides Update on Progress Toward Filing Financial Statements; Conference Call Scheduled for 10 a.m., Eastern, Today”.
This press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference.
SECTION 9—FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01. Financial Statements and Exhibits.
(a) | Financial Statements of Businesses Acquired. Not applicable. |
(b) | Pro Forma Financial Information. Not applicable. | |
(c) | Exhibits. | |
| | | |
99.1 | Press release dated June 6, 2005, entitled, “VaxGen Names Kevin Lee Acting CFO Following Resignation of James Cunha; Company Provides Update on Progress Toward Filing Financial Statements; Conference Call Scheduled for 10 a.m., Eastern, Today”. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| VaxGen, Inc. |
| (Registrant) |
| |
| |
Dated: June 7, 2005 | By: /s/ Kevin C. Lee |
| Kevin C. Lee |
| Acting Chief Financial Officer |
EXHIBIT INDEX
99.1 | Press release dated June 6, 2005 entitled, “VaxGen Names Kevin Lee Acting CFO Following Resignation of James Cunha; Company Provides Update on Progress Toward Filing Financial Statements; Conference Call Scheduled for 10 a.m., Eastern, Today”. |
